GLP-1 Insurance Checker: Find Out What Your Plan Covers
No web page can promise that your plan will pay for a GLP-1. The answer sits in the plan’s drug list and its prior authorization rules. See how each kind of insurance treats these medications, and how AM Rx’s insurance coordination team files the request that gets a firm answer.
Insurance coordination comes with AM Rx membership. The first month is $39 and each later month is $135. That price does not include medication.
What our insurance coordination team does
- Submits the prior authorization when an AM Rx provider prescribes a brand-name GLP-1: Ozempic®, Wegovy®, Zepbound® or Mounjaro®
- Hears back on most requests in 2 to 14 business days
- Can submit up to three requests if the first one is denied
- When your plan covers the medication, the copay can be as low as $25 a month
Insurers make the coverage decision. AM Rx cannot promise an approval, and a prescription is written only when a licensed provider finds the medication appropriate for you.
How does the AM Rx insurance check work?
The check is a prior authorization request, filed for you by AM Rx’s insurance coordination team after a provider has prescribed a brand-name GLP-1. It takes three steps.
Complete the online intake
Create your account and fill in the health questionnaire. A licensed provider reviews it in 1 to 2 business days, then replies by secure message. No live appointment is needed to start.
A provider decides what fits
The provider reads your health history. If a brand-name GLP-1 is appropriate for you, the provider prescribes it. Nothing is prescribed unless a licensed provider finds it appropriate.
We file the request
The team submits the prior authorization, and most decisions arrive in 2 to 14 business days. If the plan approves, the prescription is sent to the pharmacy you choose, and what you pay there may be as little as $25 a month.
An active AM Rx membership is required to keep a prior authorization active.
Why GLP-1 coverage depends on your plan
Coverage moves the price more than anything else. In a late-2025 KFF poll, 56% of adults who had used a GLP-1 said the drugs were difficult to afford, and 27% of users had insurance yet paid the whole cost themselves.1
With a plan that pays for a brand-name GLP-1, your copay may be as little as $25 a month. With no coverage, the makers’ self-pay prices as of November 2026 are $349 a month for most Wegovy pens and $299 to $699 a month for the Zepbound KwikPen, depending on dose and refill timing.2,3 And no single rule fits everyone. The same plan can pay for a GLP-1 when the diagnosis is type 2 diabetes and refuse it for weight loss.
Employer and private insurance
Most large employers do not cover GLP-1s for weight loss. In KFF’s 2026 survey of 1,937 employers, 18% of firms with 200 or more workers said their largest plan covers them for that use, against 19% in 2025. The share rises with size, from 16% of firms with 200 to 999 workers to 33% of those with 5,000 or more. Coverage also gets withdrawn: 12% of large firms without it had dropped it within the past 12 months.4
Prior authorization: what plans ask for
A prior authorization is your plan checking that you meet its conditions before it pays. Each insurer sets its own, and we do not quote any insurer’s policy here. Two patterns are documented.
One is body mass index. Weight loss medications are meant for adults whose BMI is at least 30, or at least 27 when a weight-related problem such as high blood pressure or type 2 diabetes is present.5 Our BMI calculator shows where you stand. The other is a lifestyle requirement. Of the large employers that cover these drugs for weight loss, 40% add a condition such as sessions with a dietitian or a lifestyle program.4
Medicare and the Medicare GLP-1 Bridge
Medicare’s drug benefit, Part D, is barred by law from covering drugs “when used for anorexia, weight loss, or weight gain”.6 The one opening is the Medicare GLP-1 Bridge, a temporary program that opened on July 1, 2026 and is due to close on December 31, 2027. Its rules:7
- Drugs. Foundayo® tablets, Wegovy injection or tablets, and the Zepbound KwikPen. Single-dose Zepbound pens and vials are left out.
- Cost. You pay $50 for each one-month supply. Extra Help cannot reduce that amount, and it is not credited to your Part D deductible or your out-of-pocket limit. Coupons and discount programs cannot be applied.8
- Who qualifies. Adults with Part D whose BMI at the start of treatment is 35 or more. A BMI of 30 or more qualifies with stage 3a or higher chronic kidney disease, uncontrolled high blood pressure, or heart failure with preserved ejection fraction. A BMI of 27 or more qualifies with symptomatic peripheral artery disease, prediabetes, or a heart attack or stroke in the past. Uncontrolled means above 140 systolic or above 90 diastolic despite two blood pressure medicines.8
- Who does not. Anyone whose diagnosis is type 2 diabetes, sleep apnea rated moderate to severe, or the liver disease MASH with moderate to advanced scarring, since Part D is able to pay for a GLP-1 in those cases. In 2026, a person who has already filled a GLP-1 through Part D that year is outside the Bridge too.8
- How it starts. Your prescriber sends the prescription, completes a prior authorization when asked, and confirms you are using the drug alongside a lifestyle program built on diet and exercise. The approval stays valid through December 31, 2027 unless you change GLP-1s.7 A prescription written to lower the risk of heart attack or stroke goes to the Part D plan instead.8
Medicare.gov has an eligibility questionnaire, and 1-800-MEDICARE (1-800-633-4227) takes questions.7
Medicaid
Medicaid coverage for weight loss depends on the state. Every state must cover GLP-1s for type 2 diabetes and certain other approved uses, but covering them for obesity is optional. As of January 2026, KFF counted 13 states covering them for obesity in fee-for-service Medicaid, down from 16 in October 2025. Where coverage exists, a prior authorization is typical.9
TRICARE and the VA
TRICARE covers GLP-1s for weight management, Wegovy and Zepbound among them, under Prime, Select and several other plans. You need to meet its clinical criteria and have a prescription from a network provider and a prior authorization. TRICARE For Life does not cover weight loss drugs.10
The VA’s criteria for use for Wegovy and Zepbound, revised in April 2026, call for a BMI of at least 27 together with one or more weight-related conditions, plus documented participation in a lifestyle program such as MOVE! within the past year.11
Manufacturer savings cards, and who cannot use them
Savings cards from the drug makers work only alongside commercial insurance. As of November 2026, Novo Nordisk’s Wegovy offer and Eli Lilly’s Zepbound card each cut the cost to as little as $25 a month when a commercial plan covers the drug (for Zepbound, the single-dose pen), and each excludes government beneficiaries.2,3 That shuts out anyone covered by Medicare, Medicaid, TRICARE, the VA or another government program.
The reason is the federal Anti-Kickback Statute. Copay coupons, the HHS Inspector General notes, “typically bear a statement that the coupon may not be used by beneficiaries of Federal health care programs”.12 The Zepbound card also expires on December 31, 2026.3
One more limit: Ozempic and Mounjaro hold FDA approval for type 2 diabetes and not for weight loss, which is why some plans pay for them only when diabetes is the diagnosis.13,14 Supply is a separate question. Our GLP-1 supply tracker shows which of these drugs are on the FDA’s shortage list today.
What if insurance will not pay for your GLP-1?
A denial is not always final, and it leaves you three routes.
Ask again, or appeal
If the first prior authorization is denied, AM Rx’s team can submit up to three requests. You also have appeal rights of your own. Under the federal rules set out on HealthCare.gov, a plan has 15 days to put its reasons for refusing a prior authorization in writing, and an internal appeal can be filed for up to 180 days after that notice. If the answer is still no, you can request an external review within four months, and the insurer must accept the reviewer’s decision.15
Pay the maker’s self-pay price
As of November 2026, Wegovy pens are $349 a month for doses from 0.25 mg to 2.4 mg, with a $199 introductory price on the first two fills of the two lowest doses for new patients through December 31, 2026.2 The Zepbound KwikPen is $299 a month at 2.5 mg and $399 at 5 mg. From 7.5 mg up it is $449 if you refill within 45 days, and $499 or $699, depending on the dose, if you do not.3 You still need a prescription. Our guide to GoodRx and Wegovy covers the coupon route.
Ask your provider about compounded medication
AM Rx providers can also prescribe compounded semaglutide or compounded tirzepatide when they find it appropriate. Paid monthly, semaglutide is $199 and tirzepatide is $329. With a 3-month supply the price starts at $106 a month for semaglutide and $216 a month for tirzepatide. Shipping is included, the medication comes to your home from a partner pharmacy, and HSA and FSA cards are accepted.
Compounded drugs do not have FDA approval, which means the FDA has not reviewed them for safety, effectiveness or quality.16 They are not the same products as Wegovy or Zepbound.
Important safety information. Wegovy, Zepbound, Ozempic and Mounjaro have a boxed warning on their labels: a risk of thyroid C-cell tumors. They are not for anyone who has had medullary thyroid carcinoma or has a family member who had it, for anyone with MEN 2 (Multiple Endocrine Neoplasia syndrome type 2), or for anyone who has had a serious allergic reaction to the drug. Serious risks include pancreatitis, gallbladder disease, severe stomach problems, kidney injury from dehydration and low blood sugar when taken with insulin or a sulfonylurea. The most common side effects are nausea, diarrhea, vomiting, constipation and stomach pain.13,14,17,18 The FDA is requiring all GLP-1 labels to add a warning about NAION, a rare eye condition that can cause sudden vision loss in one eye.19 Treat these warnings as applying to compounded semaglutide and tirzepatide too. Full safety sections: Zepbound, Wegovy, semaglutide and tirzepatide.
GLP-1 insurance coverage FAQs
How can I find out whether my insurance covers Zepbound or Wegovy?
Start with your plan’s drug list, called a formulary, or call the member number on your insurance card. Ask whether the drug is covered for weight loss and whether it needs a prior authorization. The firm answer comes from the prior authorization itself. For AM Rx members, the insurance coordination team submits that request once a provider has prescribed a brand-name GLP-1.
How long does a prior authorization for a GLP-1 take?
Usually 2 to 14 business days from the day AM Rx’s team sends the request. The insurer sets the pace, not us. Under the federal rules described on HealthCare.gov, a plan that turns down a prior authorization has 15 days to say why in writing.15 If the first request is denied, the team can submit up to three.
Does Medicare pay for weight loss drugs like Wegovy and Zepbound?
Not through the regular drug benefit, because the law bars Part D from covering drugs used for weight loss.6 Between July 2026 and the end of 2027, the Medicare GLP-1 Bridge gives eligible people with Part D access to Wegovy, the Zepbound KwikPen or Foundayo for $50 a month, once their prescriber completes a prior authorization.7 Medicare.gov has an eligibility questionnaire.
Can I use a manufacturer savings card with Medicare, Medicaid or TRICARE?
No. Novo Nordisk’s Wegovy offer and Eli Lilly’s Zepbound card both exclude government beneficiaries, which takes in Medicare, Medicaid, TRICARE and VA coverage.2,3 The cards work only alongside commercial insurance. Under the Medicare GLP-1 Bridge the copay is fixed at $50, and CMS states that coupons and discount programs may not be applied to it.8
Is the AM Rx coverage check free?
It is included in AM Rx membership. Membership is $39 in month one, then $135 monthly, and it also covers review by a licensed provider, unlimited secure messaging and a dedicated weight loss coach. Medication costs extra. An active membership is required to keep a prior authorization active, and you can cancel at any time in the portal.
Will I get a prescription if my plan covers a GLP-1?
Not automatically. Coverage and prescribing are separate decisions made by different people. A licensed AM Rx provider reviews your health history and prescribes a GLP-1 only when it is appropriate for you. Your plan then decides whether it will pay. A plan may cover a drug that a provider would not prescribe for you, and a provider may prescribe one that the plan declines to cover.
Sources
- KFF. KFF Health Tracking Poll: Prescription Drug Costs, Views on Trump Administration Actions, and GLP-1 Use. November 2025. https://www.kff.org/public-opinion/kff-health-tracking-poll-prescription-drug-costs-views-on-trump-administration-actions-and-glp-1-use/
- Novo Nordisk. What to pay for Wegovy (savings offer and self-pay prices as displayed November 19, 2026). https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html
- Eli Lilly and Company. Zepbound coverage and savings (savings card terms and self-pay prices as displayed November 19, 2026). https://zepbound.lilly.com/coverage-savings
- KFF. 2026 Employer Health Benefits Survey. October 2026. https://www.kff.org/health-costs/2026-employer-health-benefits-survey/
- National Institute of Diabetes and Digestive and Kidney Diseases. Prescription Medications to Treat Overweight and Obesity. Reviewed June 2024. https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity
- 42 U.S.C. 1395w-102(e)(2)(A) and 42 U.S.C. 1396r-8(d)(2)(A). Cornell Legal Information Institute. https://www.law.cornell.edu/uscode/text/42/1395w-102 and https://www.law.cornell.edu/uscode/text/42/1396r-8
- Medicare.gov. Weight loss drugs (Medicare GLP-1 Bridge). https://www.medicare.gov/coverage/weight-loss-drugs
- Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge: Information for Part D Plans. https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-part-d-plans
- KFF. Medicaid Coverage of and Spending on GLP-1s. January 16, 2026. https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/
- TRICARE. Does TRICARE cover Wegovy, Ozempic, and Mounjaro? Updated August 6, 2026. https://www.tricare.mil/FAQs/Pharmacy/PharmProg_Wegovy
- U.S. Department of Veterans Affairs, Pharmacy Benefits Management. Criteria for Use: Semaglutide (Wegovy) for Weight Management, and Tirzepatide (Zepbound) for Weight Management. April 2026. https://www.va.gov/formularyadvisor/DOC_PDF/CFU_Semaglutide_WEGOVY_for_weight_management_CFU_Rev_Apr_2026.pdf and https://www.va.gov/formularyadvisor/DOC_PDF/CFU_Tirzepatide_ZEPBOUND_for_weight_management_CFU_Rev_April_2026.pdf
- HHS Office of Inspector General. Special Advisory Bulletin: Pharmaceutical Manufacturer Copayment Coupons. September 2014. https://oig.hhs.gov/documents/special-advisory-bulletins/878/SAB_Copayment_Coupons.pdf
- Ozempic (semaglutide) injection. Prescribing Information. Novo Nordisk. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
- Mounjaro (tirzepatide). Prescribing Information. Eli Lilly and Company. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
- HealthCare.gov. Internal appeals, and External review. https://www.healthcare.gov/appeal-insurance-company-decision/internal-appeals/ and https://www.healthcare.gov/appeal-insurance-company-decision/external-review/
- U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- Wegovy (semaglutide) injection and tablets. Prescribing Information. Novo Nordisk. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- Zepbound (tirzepatide). Prescribing Information. Eli Lilly and Company. Revised 08/2026. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- U.S. Food and Drug Administration. FDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition. Drug Safety Communication. November 9, 2026. https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential
Let our insurance team put the question to your plan
The health questionnaire takes a few minutes and is read by a licensed provider. Your first month of AM Rx membership is $39.

A provider prescribes. Our coordinators deal with your plan.
AM Rx providers are U.S.-licensed, board-certified physicians and nurse practitioners. When one of them prescribes a brand-name GLP-1, the insurance coordination team takes the prior authorization from there.
The AM Rx care team checks the medical content of this page against FDA prescribing information and published clinical trials. It is general health education and does not replace advice from your own provider.
AM Rx members, in their own words
One of the things I appreciate most about semaglutide is its convenience. The once-weekly dosing schedule has made it incredibly easy to integrate into my routine. It's a relief to know that I don't have to worry about multiple daily injections or complicated medication schedules.
I started semaglutide at the recommendation of my AM Rx provider and I'm so happy with that decision. I signed up for their weight loss program and they've been giving me everything I need to make better lifestyle choices to get results that last. And the program's super affordable. 10/10 I can't recommend this enough.
Getting support a weight loss program has always been hard for me. I had been wanting to start one with a medication component for a while and AM Rx was the first one that made it easy for me with weight loss shots sent to me. They made it SO affordable and the medical team is great.
Since I started AM Rx, I have already lost 35 pounds and feel so much better. My doctor also helped me get a prescription for ozempic and he is always available to answer my questions in the message portal. This made me feel a lot more comfortable and excited to lose weight.
The weight loss program is fantastic. Everyone has been so helpful and has helped me feel much more excited about the process. I was nervous to see my weight loss treatment plan, since I have done programs in the past, but they always wanted me to make drastic changes. I mentioned all of this to my weight loss coach and she was very understanding and made a customized plan for me.
I've been a member for 6 months now and have received all my medication every 3 months. Everyone has been so helpful and my care team is always available to help me!
Individual results may vary. These reviews describe the experience of individual AM Rx members and do not promise any result. Medication is prescribed only if a licensed provider considers it appropriate.
The GLP-1 medications AM Rx providers prescribe
Four brand-name medications and two compounded options. Which one you are offered depends on your health history and a licensed provider’s judgment, and our insurance coordinators file the prior authorization when a brand-name drug is prescribed.
Zepbound®
Weekly tirzepatide. FDA-approved for chronic weight management and for obstructive sleep apnea in adults with obesity.
Zepbound cost, coupons and side effects →Wegovy®
Semaglutide for chronic weight management, FDA-approved as a weekly injection and as a once-daily tablet.
Wegovy pill, price and side effects →Mounjaro®
Weekly tirzepatide with an FDA approval for type 2 diabetes. It shares its active ingredient with Zepbound.
Mounjaro doses and savings card →Ozempic®
Weekly semaglutide with an FDA approval for type 2 diabetes. Using it for weight loss is off-label.
Ozempic side effects and cost →Compounded semaglutide
$199 a month, or from $106 a month when you order a 3-month supply. Shipping is included. Not FDA-approved.
Semaglutide cost and dosing →Compounded tirzepatide
$329 a month, or from $216 a month when you order a 3-month supply. Shipping is included. Not FDA-approved.
Tirzepatide dosage and cost →A partner pharmacy prepares compounded medication for one patient’s prescription at a time. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality. AM Rx membership costs $39 for the first month and $135 a month after that, and is charged separately from medication. Nothing is prescribed unless a licensed provider finds it appropriate.